Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
876
New Jersey Resources
NJR
$5.2B
| $14.1M | 0.02% |
314,200
+138,200
| +79% | +$6.48M |
2024 Q1
5 quarters
|
|
877
First Trust Senior Loan Fund ETF
FTSL
$2.43B
| $14.1M | 0.02% |
306,300
+246,300
| +411% | +$11.2M |
2022 Q4
10 quarters
|
|
878
Tower Semiconductor
TSEM
$25.9B
| $14M | 0.02% |
323,649
-107,086
| -25% | -$4.11M |
2016 Q1
37 quarters
|
|
879
Credit Acceptance
CACC
$5.68B
| $14M | 0.02% |
27,488
+25,988
| +1,733% | +$12.8M |
2024 Q1
5 quarters
|
|
880
Leidos
LDOS
$15.3B
| $14M | 0.02% |
88,550
-220,500
| -71% | -$32.6M |
2023 Q4
6 quarters
|
|
881
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.21B
| $13.9M | 0.02% |
377,700
-39,000
| -9% | -$1.41M |
2024 Q1
5 quarters
|
|
|
VRNA
882
DELISTED
Verona Pharma
VRNA
| $13.9M | 0.02% |
147,400
+48,400
| +49% | +$3.58M |
2024 Q4
2 quarters
|
|
883
Sportradar
SRAD
$3.69B
| $13.9M | 0.02% |
496,200
-84,500
| -15% | -$2.01M |
2022 Q2
12 quarters
|
|
884
LSB Industries
LXU
$706M
| $13.8M | 0.02% |
1,766,593
+23,600
| +1% | +$162K |
2018 Q3
27 quarters
|
|
885
RBC Bearings
RBC
$15.9B
| $13.8M | 0.02% |
35,800
+2,600
| +8% | +$918K |
2024 Q2
4 quarters
|
|
|
TXNM
886
TXNM Energy Inc
TXNM
$6.45B
| $13.8M | 0.02% |
244,284
-204,500
| -46% | -$11.1M |
2013 Q2
48 quarters
|
|
887
Bunge Global
BG
$19.7B
| $13.7M | 0.02% |
171,100
+123,000
| +256% | +$9.68M |
2025 Q1
1 quarter
|
|
888
ZTO Express
ZTO
$15.1B
| $13.7M | 0.02% |
772,300
-414,800
| -35% | -$7.51M |
2022 Q1
13 quarters
|
|
889
Castle Biosciences
CSTL
$1.05B
| $13.7M | 0.02% |
670,500
-30,700
| -4% | -$568K |
2021 Q4
14 quarters
|
|
890
BorgWarner
BWA
$12.5B
| $13.7M | 0.02% |
+408,798
| New | +$12.5M |
2025 Q2
0 quarters
|
|
|
PBPB
891
DELISTED
Potbelly
PBPB
| $13.6M | 0.02% |
1,113,554
-13,100
| -1% | -$129K |
2014 Q4
42 quarters
|
|
892
Dole
DOLE
$1.24B
| $13.6M | 0.02% |
974,300
+45,600
| +5% | +$646K |
2021 Q4
14 quarters
|
|
893
Realty Income
O
$51.3B
| $13.6M | 0.02% |
+236,144
| New | +$13.4M |
2025 Q2
0 quarters
|
|
|
HDSN
894
Hudson Technologies
HDSN
$216M
| $13.6M | 0.02% |
1,671,850
+183,500
| +12% | +$1.26M |
2020 Q4
18 quarters
|
|
895
MYR Group
MYRG
$4.85B
| $13.6M | 0.02% |
+74,800
| New | +$11M |
2025 Q2
0 quarters
|
|
896
Host Hotels & Resorts
HST
$15.5B
| $13.5M | 0.02% |
881,800
+662,700
| +302% | +$9.82M |
2025 Q1
1 quarter
|
|
|
PRA
897
DELISTED
ProAssurance
PRA
| $13.5M | 0.02% |
590,500
-139,200
| -19% | -$3.21M |
2014 Q4
42 quarters
|
|
898
Atlanta Braves Holdings Series A
BATRA
$3.69B
| $13.5M | 0.02% |
273,700
-10,500
| -4% | -$464K |
2017 Q1
33 quarters
|
|
899
Under Armour
UAA
$2.12B
| $13.4M | 0.02% |
1,968,400
-2,838,694
| -59% | -$17.7M |
2024 Q3
3 quarters
|
|
900
FLEX LNG
FLNG
$1.67B
| $13.4M | 0.02% |
611,335
-58,862
| -9% | -$1.38M |
2023 Q1
9 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.